2026-01-23 - Analysis Report
**Welltower (WELL) Financial Report**

### General Overview
Welltower is a healthcare real estate investment trust (REIT) that owns a diversified portfolio of healthcare properties, including medical offices, hospitals, and skilled nursing facilities.

### Return Rate Comparison
- Cumulative return of review stock (Welltower): 117.30%
- Cumulative return of comparison stock (S&P 500, VOO): 92.53%
- Divergence (max: 59.10, min: -39.60, current: 35.20, relative divergence: 75.80%)

### Alpha, Beta Analysis
| Year       | CAGR (%) | MDD (%) | Alpha (%) | Beta | Cap (B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 14.0% | 15.3% | 9.0% | 0.5 | 47.6B |
| 2017-2019  | 24.0% | 15.3% | 7.0% | 0.3 | 56.1B |
| 2018-2020  | 39.0% | 30.5% | 18.0% | 1.1 | 44.4B |
| 2019-2021  | 19.0% | 30.5% | -25.0% | 1.3 | 58.9B |
| 2020-2022  | -15.0% | 34.0% | -13.0% | 1.1 | 45.0B |
| 2021-2023  | 6.0% | 34.0% | 5.0% | 0.7 | 61.9B |
| 2022-2024  | 29.0% | 34.0% | 10.0% | 0.6 | 86.5B |
| 2023-2025  | 98.0% | 12.4% | 36.0% | 0.5 | 127.4B |

### Recent Stock Price Fluctuations
- Close: $181.96
- Last-market: $181.96 ($-2.17)
- 5-day SMA: $187.10
- 20-day SMA: $187.01
- 60-day SMA: $190.84

### RSI, PPO Index Indicators and Other Analysis
- Market Risk Indicator (MRI): 0.90 (High Investment Recommended)
- RSI: 41.32
- PPO: -0.03
- Recent (20 days) relative divergence change: +7.00 (improving)
- 7-day Rank change: +15 (rank up)
- 7-day Dynamic Expected Return change: +0.20 (improving)
- Expected Return (%): -0.90%

### Recent News & Significant Events
- [2026-01-21] Stock Market Today, Jan. 21: Vale Jumps After Trading Volume Surges Well Above Average - Nasdaq
- [2026-01-20] Gladstone Commercial (GOOD) Stock Moves -1.28%: What You Should Know - Yahoo Finance
- [2026-01-22] (WELL) Dynamic Trading Report (WELL:CA) - Stock Traders Daily
- [2026-01-21] Murphy Oil Stock (-10%): Civette Well Disappointment Derails Exploration Narrative - Trefis
- [2026-01-22] Is Rivian Stock a Good Buy? Expert Analysis for 2026 - Intellectia AI
- [2026-01-19] Welltower Stock Gains 19.4% in 6 Months: Will it Continue to Rise? - Finviz

### Analyst Opinions
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.65 (~Buy)
- Opinions: 20
- Target Price (avg/high/low): $209.70 / $260.00 / $162.00

### Recent Earnings Analysis
| Date | EPS | Revenue (B$) |
|-----|----|---------------|
| 2025-10-28 | 0.42 | 2.06 |
| 2025-07-29 | 0.46 | 1.97 |
| 2025-04-29 | 0.4 | 1.86 |
| 2024-10-29 | 0.74 | 1.51 |
| 2025-10-28 | 0.74 | 1.51 |

### Financial Information - Revenue and Profitability
| Quarter | Revenue (B$) | Profit Margin (%) |
|---------|---------------|---------------|
| 2025-09-30 | $2.63B | 39.99% |
| 2025-06-30 | $2.52B | 39.80% |
| 2025-03-31 | $2.39B | 38.78% |
| 2024-12-31 | $2.22B | 36.50% |
| 2024-09-30 | $2.01B | 39.70% |

### Financial Information - Capital and Profitability
| Quarter | Equity (B$) | ROE (%) |
|---------|---------|-----|
| 2025-09-30 | $38.76B | 0.72% |
| 2025-06-30 | $35.90B | 0.84% |
| 2025-03-31 | $33.96B | 0.76% |
| 2024-12-31 | $31.96B | 0.38% |
| 2024-09-30 | $30.33B | 1.48% |

### Comprehensive Analysis
Based on the provided data, Welltower's cumulative return exceeds the S&P 500's cumulative return, indicating a positive outperformance. However, the relative divergence is high, indicating a potential risk. The Alpha, Beta analysis suggests mixed results, with both positive and negative Alpha values throughout different periods. The recent stock price fluctuations show a decline in the past 5 days, while the SMAs suggest a longer-term uptrend. The RSI and PPO indicators indicate a bearish trend, with the RSI at 41.32 and the PPO at -0.03. The Market Risk Indicator suggests a high-risk investment. The recent news and significant events show a mix of both positive and negative news. The analyst opinions suggest a Buy rating with a target price of $209.70. Finally, the recent earnings analysis shows mixed results, with both positive and negative EPS and revenue growth. The financial information shows a steady revenue and profit margin growth, but ROE has declined in the past quarter.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.